vs
博士伦（BLCO）与ROKU, INC（ROKU）财务数据对比。点击上方公司名可切换其他公司
博士伦的季度营收约是ROKU, INC的1.0倍（$1.4B vs $1.4B），ROKU, INC净利率更高（5.8% vs -4.1%，领先9.9%），ROKU, INC同比增速更快（16.1% vs 9.8%），ROKU, INC自由现金流更多（$106.6M vs $60.0M），过去两年ROKU, INC的营收复合增速更高（25.8% vs 13.1%）
博士伦是知名眼健康产品企业，总部位于加拿大安大略省沃恩市，是全球规模最大的隐形眼镜、镜片护理产品、眼科药品、人工晶体及其他眼科手术产品供应商之一。品牌1853年由验光师约翰·鲍什与合伙人亨利·朗姆在美国纽约罗切斯特创立，曾是美国历史最悠久的持续运营企业之一，2013年被整体收购。
Roku是美国流媒体技术企业，2002年由安东尼·伍德创立，主营数字媒体播放器、电视硬件生产，流媒体内容分发及平台广告运营。截至2024年覆盖用户达1.45亿，是美国流媒体视频分发领域的市场领导者，业务覆盖澳、加、法、德、英及拉美多国。
BLCO vs ROKU — 直观对比
营收规模更大
BLCO
是对方的1.0倍
$1.4B
营收增速更快
ROKU
高出6.4%
9.8%
净利率更高
ROKU
高出9.9%
-4.1%
自由现金流更多
ROKU
多$46.6M
$60.0M
两年增速更快
ROKU
近两年复合增速
13.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.4B | $1.4B |
| 净利润 | $-58.0M | $80.5M |
| 毛利率 | — | 43.5% |
| 营业利润率 | 8.0% | 4.7% |
| 净利率 | -4.1% | 5.8% |
| 营收同比 | 9.8% | 16.1% |
| 净利润同比 | -1833.3% | 326.4% |
| 每股收益（稀释后） | $-0.16 | $0.55 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BLCOROKU
| Q4 25 | $1.4B | $1.4B | ||
| Q3 25 | $1.3B | $1.2B | ||
| Q2 25 | $1.3B | $1.1B | ||
| Q1 25 | $1.1B | $1.0B | ||
| Q4 24 | $1.3B | $1.2B | ||
| Q3 24 | $1.2B | $1.1B | ||
| Q2 24 | $1.2B | $968.2M | ||
| Q1 24 | $1.1B | $881.5M |
净利润BLCOROKU
| Q4 25 | $-58.0M | $80.5M | ||
| Q3 25 | $-28.0M | $24.8M | ||
| Q2 25 | $-62.0M | $10.5M | ||
| Q1 25 | $-212.0M | $-27.4M | ||
| Q4 24 | $-3.0M | $-35.5M | ||
| Q3 24 | $4.0M | $-9.0M | ||
| Q2 24 | $-151.0M | $-34.0M | ||
| Q1 24 | $-167.0M | $-50.9M |
毛利率BLCOROKU
| Q4 25 | — | 43.5% | ||
| Q3 25 | — | 43.4% | ||
| Q2 25 | — | 44.8% | ||
| Q1 25 | — | 43.6% | ||
| Q4 24 | — | 42.7% | ||
| Q3 24 | — | 45.2% | ||
| Q2 24 | — | 43.9% | ||
| Q1 24 | — | 44.1% |
营业利润率BLCOROKU
| Q4 25 | 8.0% | 4.7% | ||
| Q3 25 | 7.4% | 0.8% | ||
| Q2 25 | -0.9% | -2.1% | ||
| Q1 25 | -7.3% | -5.7% | ||
| Q4 24 | 6.8% | -3.3% | ||
| Q3 24 | 3.6% | -3.4% | ||
| Q2 24 | 2.1% | -7.4% | ||
| Q1 24 | 0.5% | -8.2% |
净利率BLCOROKU
| Q4 25 | -4.1% | 5.8% | ||
| Q3 25 | -2.2% | 2.0% | ||
| Q2 25 | -4.9% | 0.9% | ||
| Q1 25 | -18.6% | -2.7% | ||
| Q4 24 | -0.2% | -3.0% | ||
| Q3 24 | 0.3% | -0.9% | ||
| Q2 24 | -12.4% | -3.5% | ||
| Q1 24 | -15.2% | -5.8% |
每股收益（稀释后）BLCOROKU
| Q4 25 | $-0.16 | $0.55 | ||
| Q3 25 | $-0.08 | $0.16 | ||
| Q2 25 | $-0.18 | $0.07 | ||
| Q1 25 | $-0.60 | $-0.19 | ||
| Q4 24 | $-0.00 | $-0.24 | ||
| Q3 24 | $0.01 | $-0.06 | ||
| Q2 24 | $-0.43 | $-0.24 | ||
| Q1 24 | $-0.48 | $-0.35 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $383.0M | $2.3B |
| 总债务越低越好 | $5.0B | — |
| 股东权益账面价值 | $6.4B | $2.7B |
| 总资产 | $14.0B | $4.4B |
| 负债/权益比越低杠杆越低 | 0.78× | — |
8季度趋势，按日历期对齐
现金及短期投资BLCOROKU
| Q4 25 | $383.0M | $2.3B | ||
| Q3 25 | $310.0M | $2.3B | ||
| Q2 25 | $266.0M | $2.3B | ||
| Q1 25 | $202.0M | $2.3B | ||
| Q4 24 | $305.0M | $2.2B | ||
| Q3 24 | $329.0M | $2.1B | ||
| Q2 24 | $285.0M | $2.1B | ||
| Q1 24 | $315.0M | $2.1B |
总债务BLCOROKU
| Q4 25 | $5.0B | — | ||
| Q3 25 | $5.0B | — | ||
| Q2 25 | $5.0B | — | ||
| Q1 25 | $4.8B | — | ||
| Q4 24 | $4.8B | — | ||
| Q3 24 | $4.6B | — | ||
| Q2 24 | $4.6B | — | ||
| Q1 24 | $4.6B | — |
股东权益BLCOROKU
| Q4 25 | $6.4B | $2.7B | ||
| Q3 25 | $6.4B | $2.6B | ||
| Q2 25 | $6.4B | $2.6B | ||
| Q1 25 | $6.4B | $2.5B | ||
| Q4 24 | $6.5B | $2.5B | ||
| Q3 24 | $6.6B | $2.5B | ||
| Q2 24 | $6.5B | $2.4B | ||
| Q1 24 | $6.7B | $2.4B |
总资产BLCOROKU
| Q4 25 | $14.0B | $4.4B | ||
| Q3 25 | $13.8B | $4.4B | ||
| Q2 25 | $13.8B | $4.3B | ||
| Q1 25 | $13.4B | $4.2B | ||
| Q4 24 | $13.5B | $4.3B | ||
| Q3 24 | $13.5B | $4.3B | ||
| Q2 24 | $13.3B | $4.1B | ||
| Q1 24 | $13.3B | $4.2B |
负债/权益比BLCOROKU
| Q4 25 | 0.78× | — | ||
| Q3 25 | 0.77× | — | ||
| Q2 25 | 0.77× | — | ||
| Q1 25 | 0.76× | — | ||
| Q4 24 | 0.74× | — | ||
| Q3 24 | 0.70× | — | ||
| Q2 24 | 0.71× | — | ||
| Q1 24 | 0.69× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $136.0M | $107.7M |
| 自由现金流经营现金流 - 资本支出 | $60.0M | $106.6M |
| 自由现金流率自由现金流/营收 | 4.3% | 7.6% |
| 资本支出强度资本支出/营收 | 5.4% | 0.1% |
| 现金转化率经营现金流/净利润 | — | 1.34× |
| 过去12个月自由现金流最近4个季度 | $-66.0M | $478.4M |
8季度趋势，按日历期对齐
经营现金流BLCOROKU
| Q4 25 | $136.0M | $107.7M | ||
| Q3 25 | $137.0M | $127.6M | ||
| Q2 25 | $35.0M | $109.7M | ||
| Q1 25 | $-25.0M | $138.7M | ||
| Q4 24 | $22.0M | $79.3M | ||
| Q3 24 | $154.0M | $68.7M | ||
| Q2 24 | $15.0M | $23.4M | ||
| Q1 24 | $41.0M | $46.7M |
自由现金流BLCOROKU
| Q4 25 | $60.0M | $106.6M | ||
| Q3 25 | $63.0M | $126.5M | ||
| Q2 25 | $-54.0M | $108.6M | ||
| Q1 25 | $-135.0M | $136.8M | ||
| Q4 24 | $-70.0M | $76.8M | ||
| Q3 24 | $94.0M | $67.6M | ||
| Q2 24 | $-57.0M | $22.5M | ||
| Q1 24 | $-26.0M | $46.0M |
自由现金流率BLCOROKU
| Q4 25 | 4.3% | 7.6% | ||
| Q3 25 | 4.9% | 10.4% | ||
| Q2 25 | -4.2% | 9.8% | ||
| Q1 25 | -11.9% | 13.4% | ||
| Q4 24 | -5.5% | 6.4% | ||
| Q3 24 | 7.9% | 6.4% | ||
| Q2 24 | -4.7% | 2.3% | ||
| Q1 24 | -2.4% | 5.2% |
资本支出强度BLCOROKU
| Q4 25 | 5.4% | 0.1% | ||
| Q3 25 | 5.8% | 0.1% | ||
| Q2 25 | 7.0% | 0.1% | ||
| Q1 25 | 9.7% | 0.2% | ||
| Q4 24 | 7.2% | 0.2% | ||
| Q3 24 | 5.0% | 0.1% | ||
| Q2 24 | 5.9% | 0.1% | ||
| Q1 24 | 6.1% | 0.1% |
现金转化率BLCOROKU
| Q4 25 | — | 1.34× | ||
| Q3 25 | — | 5.14× | ||
| Q2 25 | — | 10.45× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 38.50× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BLCO
| Overthe Counter Products | $489.0M | 35% |
| Pharmaceuticals | $378.0M | 27% |
| Other | $263.0M | 19% |
| Surgical | $249.0M | 18% |
| Brandedand Other Generic Products | $14.0M | 1% |
| Other Revenues | $3.0M | 0% |
| Pharmaceutical Products | $2.0M | 0% |
ROKU
| Services | $1.2B | 88% |
| Products | $170.9M | 12% |
